Back
  • Oral presentation
  • T62

The Toxoplasma secreted effector TgWIP modulates dendritic cell motility by activating host tyrosine phosphatases Shp1 and Shp2

Appointment

Date:
Time:
Talk time:
Discussion time:
Location / Stream:
Goethe-Saal & Galerie

Session

Session X: Parasite-Host Interactions & Signalling II

Topic

  • Host-Parasite Interaction & Signalling

Authors

Pavel Morales (Davis, CA / US), Abbigale J. Brown (Ames, IA / US), Dr. Lamba Omar Sangare (Davis, CA / US), Sheng Yang (Ames, IA / US), Simon V.N.P Kuihon (Ames, IA / US), Professor Baoyu Chen (Ames, IA / US), Professor Jeroen P.J. Saeij (Davis, CA / US)

Abstract

The obligate intracellular parasite Toxoplasma gondii causes life-threatening toxoplasmosis to immunocompromised individuals. The pathogenesis of Toxoplasma relies on its swift dissemination to the central nervous system through a "Trojan Horse" mechanism using infected leukocytes as carriers. Previous work found TgWIP, a protein secreted from Toxoplasma, played a role in altering the actin cytoskeleton and promoting cell migration in infected dendritic cells (DCs). However, the mechanism behind these changes was unknown. Our results show that TgWIP harbors two SH2-binding motifs that interact with tyrosine phosphatases Shp1 and Shp2, leading to phosphatase activation. DCs infected with Toxoplasma exhibited hypermigration, accompanying enhanced F-actin stress fibers and increased membrane protrusions such as filopodia and pseudopodia. By contrast, these phenotypes were abrogated in DCs infected with Toxoplasma expressing a mutant TgWIP lacking the SH2-binding motifs. We further showed that wildtype infected DCs treated with a Shp1/2 inhibitor no longer induced the F-actin stress fiber phenotype and hypermigration. Finally, we demonstrated that the Rho-associated kinase (Rock) is involved in the induction of these phenotypes, in a TgWIP-Shp1/2 dependent manner. Collectively, the data uncover a molecular mechanism by which TgWIP modulates the migration dynamics of infected DCs in vitro.

    • v1.20.0
    • © Conventus Congressmanagement & Marketing GmbH
    • Imprint
    • Privacy